Vaccines
WHO Advances Plans for an Ebola Vaccine Trial as a DRC Outbreak Surges
With more than 2,000 dead in what may become the second-largest Ebola epidemic ever, WHO is moving to test Merck’s Ervebo vaccine in a Phase 3 trial in Congo.